Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish

Tumour-associated angiogenesis play key roles in tumour growth and cancer metastasis. Consequently, several anti-angiogenic drugs such as sunitinib and axitinib have been approved for use as anti-cancer therapies. However, the majority of these drugs target the vascular endothelial growth factor A (...

Full description

Bibliographic Details
Main Authors: Mei Fong Ng, Juliana Da Silva Viana, Pei Jean Tan, Denver D. Britto, Sy Bing Choi, Sakurako Kobayashi, Norazwana Samat, Dedrick Soon Seng Song, Satoshi Ogawa, Ishwar S. Parhar, Jonathan W. Astin, Benjamin M. Hogan, Vyomesh Patel, Kazuhide S. Okuda
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/1/108
_version_ 1797342791155580928
author Mei Fong Ng
Juliana Da Silva Viana
Pei Jean Tan
Denver D. Britto
Sy Bing Choi
Sakurako Kobayashi
Norazwana Samat
Dedrick Soon Seng Song
Satoshi Ogawa
Ishwar S. Parhar
Jonathan W. Astin
Benjamin M. Hogan
Vyomesh Patel
Kazuhide S. Okuda
author_facet Mei Fong Ng
Juliana Da Silva Viana
Pei Jean Tan
Denver D. Britto
Sy Bing Choi
Sakurako Kobayashi
Norazwana Samat
Dedrick Soon Seng Song
Satoshi Ogawa
Ishwar S. Parhar
Jonathan W. Astin
Benjamin M. Hogan
Vyomesh Patel
Kazuhide S. Okuda
author_sort Mei Fong Ng
collection DOAJ
description Tumour-associated angiogenesis play key roles in tumour growth and cancer metastasis. Consequently, several anti-angiogenic drugs such as sunitinib and axitinib have been approved for use as anti-cancer therapies. However, the majority of these drugs target the vascular endothelial growth factor A (VEGFA)/VEGF receptor 2 (VEGFR2) pathway and have shown mixed outcome, largely due to development of resistances and increased tumour aggressiveness. In this study, we used the zebrafish model to screen for novel anti-angiogenic molecules from a library of compounds derived from natural products. From this, we identified canthin-6-one, an indole alkaloid, which inhibited zebrafish intersegmental vessel (ISV) and sub-intestinal vessel development. Further characterisation revealed that treatment of canthin-6-one reduced ISV endothelial cell number and inhibited proliferation of human umbilical vein endothelial cells (HUVECs), suggesting that canthin-6-one inhibits endothelial cell proliferation. Of note, canthin-6-one did not inhibit VEGFA-induced phosphorylation of VEGFR2 in HUVECs and downstream phosphorylation of extracellular signal-regulated kinase (Erk) in leading ISV endothelial cells in zebrafish, suggesting that canthin-6-one inhibits angiogenesis independent of the VEGFA/VEGFR2 pathway. Importantly, we found that canthin-6-one impairs tumour-associated angiogenesis in a zebrafish B16F10 melanoma cell xenograft model and synergises with VEGFR inhibitor sunitinib malate to inhibit developmental angiogenesis. In summary, we showed that canthin-6-one exhibits anti-angiogenic properties in both developmental and pathological contexts in zebrafish, independent of the VEGFA/VEGFR2 pathway and demonstrate that canthin-6-one may hold value for further development as a novel anti-angiogenic drug.
first_indexed 2024-03-08T10:38:22Z
format Article
id doaj.art-5fb5f72b7457456c83d2000c4f68f22a
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-08T10:38:22Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-5fb5f72b7457456c83d2000c4f68f22a2024-01-26T18:06:05ZengMDPI AGPharmaceuticals1424-82472024-01-0117110810.3390/ph17010108Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in ZebrafishMei Fong Ng0Juliana Da Silva Viana1Pei Jean Tan2Denver D. Britto3Sy Bing Choi4Sakurako Kobayashi5Norazwana Samat6Dedrick Soon Seng Song7Satoshi Ogawa8Ishwar S. Parhar9Jonathan W. Astin10Benjamin M. Hogan11Vyomesh Patel12Kazuhide S. Okuda13Cancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaCancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaDepartment of Molecular Medicine & Pathology, School of Medical Sciences, The University of Auckland, Auckland 1010, New ZealandDepartment of Biotechnology, Faculty of Applied Sciences, UCSI University, Cheras 56000, Kuala Lumpur, MalaysiaOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaCancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaCancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaBrain Research Institute, School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Selangor, MalaysiaBrain Research Institute, School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Selangor, MalaysiaDepartment of Molecular Medicine & Pathology, School of Medical Sciences, The University of Auckland, Auckland 1010, New ZealandOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaCancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaCancer Research Malaysia, Subang Jaya 47500, Selangor, MalaysiaTumour-associated angiogenesis play key roles in tumour growth and cancer metastasis. Consequently, several anti-angiogenic drugs such as sunitinib and axitinib have been approved for use as anti-cancer therapies. However, the majority of these drugs target the vascular endothelial growth factor A (VEGFA)/VEGF receptor 2 (VEGFR2) pathway and have shown mixed outcome, largely due to development of resistances and increased tumour aggressiveness. In this study, we used the zebrafish model to screen for novel anti-angiogenic molecules from a library of compounds derived from natural products. From this, we identified canthin-6-one, an indole alkaloid, which inhibited zebrafish intersegmental vessel (ISV) and sub-intestinal vessel development. Further characterisation revealed that treatment of canthin-6-one reduced ISV endothelial cell number and inhibited proliferation of human umbilical vein endothelial cells (HUVECs), suggesting that canthin-6-one inhibits endothelial cell proliferation. Of note, canthin-6-one did not inhibit VEGFA-induced phosphorylation of VEGFR2 in HUVECs and downstream phosphorylation of extracellular signal-regulated kinase (Erk) in leading ISV endothelial cells in zebrafish, suggesting that canthin-6-one inhibits angiogenesis independent of the VEGFA/VEGFR2 pathway. Importantly, we found that canthin-6-one impairs tumour-associated angiogenesis in a zebrafish B16F10 melanoma cell xenograft model and synergises with VEGFR inhibitor sunitinib malate to inhibit developmental angiogenesis. In summary, we showed that canthin-6-one exhibits anti-angiogenic properties in both developmental and pathological contexts in zebrafish, independent of the VEGFA/VEGFR2 pathway and demonstrate that canthin-6-one may hold value for further development as a novel anti-angiogenic drug.https://www.mdpi.com/1424-8247/17/1/108angiogenesiszebrafishcancercanthin-6-onenatural product
spellingShingle Mei Fong Ng
Juliana Da Silva Viana
Pei Jean Tan
Denver D. Britto
Sy Bing Choi
Sakurako Kobayashi
Norazwana Samat
Dedrick Soon Seng Song
Satoshi Ogawa
Ishwar S. Parhar
Jonathan W. Astin
Benjamin M. Hogan
Vyomesh Patel
Kazuhide S. Okuda
Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
Pharmaceuticals
angiogenesis
zebrafish
cancer
canthin-6-one
natural product
title Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
title_full Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
title_fullStr Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
title_full_unstemmed Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
title_short Canthin-6-One Inhibits Developmental and Tumour-Associated Angiogenesis in Zebrafish
title_sort canthin 6 one inhibits developmental and tumour associated angiogenesis in zebrafish
topic angiogenesis
zebrafish
cancer
canthin-6-one
natural product
url https://www.mdpi.com/1424-8247/17/1/108
work_keys_str_mv AT meifongng canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT julianadasilvaviana canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT peijeantan canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT denverdbritto canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT sybingchoi canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT sakurakokobayashi canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT norazwanasamat canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT dedricksoonsengsong canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT satoshiogawa canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT ishwarsparhar canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT jonathanwastin canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT benjaminmhogan canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT vyomeshpatel canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish
AT kazuhidesokuda canthin6oneinhibitsdevelopmentalandtumourassociatedangiogenesisinzebrafish